Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease. Wei W, Kong N, Liu MZ, Han T, et al. Biochem Biophys Res Commun 2022;616:8-13.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wei W, Kong N, Liu MZ, Han T, et al. Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease. Biochem Biophys Res Commun 2022;616:8-13.
PMID: 35636257